Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Intuitive Surgical    ISRG

INTUITIVE SURGICAL (ISRG)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Intuitive Surgical, Inc. : Hagens Berman Notifies Investors of June 25, 2013, Lead Plaintiff Deadline in Intuitive Surgical, Inc. Securities Class Action

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/29/2013 | 03:30pm CEST

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today notified investors of a pending June 25, 2013, deadline to file for lead plaintiff in a securities class-action lawsuit brought again Intuitive Surgical, Inc. (NASDAQ: ISRG) ("ISRG" or "the company"). The firm encourages investors with more than $500,000 in losses to contact Hagens Berman Partner Reed Kathrein to discuss moving for lead plaintiff by emailing [email protected] or calling (510) 725-3000.

Investors who purchased ISRG common stock between Oct. 19, 2011, and April 18, 2013, (the "class period") and have more than $500,000 in losses can also reach an attorney by visiting http://www.hb-securities.com/investigations/ISRG.

The lawsuit, filed in U.S. District Court for the Northern District of California on April 26, 2013, alleges that ISRG issued a series of false or misleading statements to investors during the class period. The suit alleges that ISRG failed to fully disclose to investors the financial impact of safety problems with its da Vinci Surgical System, including a number of deaths allegedly caused by the system.

A number of lawsuits have been filed against the company seeking damages for injuries caused by da Vinci. Following media coverage of those suits, ISRG's stock price suffered a significant decline. The filed investor lawsuit claims that ISRG deceived investors regarding the risk of Food and Drug Administration action against the company.

"We are concerned that ISRG failed to come clean with investors, especially in light of a significant number of deaths reported to the FDA," said Mr. Kathrein. "We are concerned that the company may be exposed to significant financial losses, either due to potential FDA restrictions on da Vinci or damages in pending personal injury lawsuits."

Investors who wish to serve as lead plaintiff in the case must move the court no later than June 25, 2013. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Hagens Berman reminds whistleblowers with inside information that rewards may be available to individuals who report information leading to a successful enforcement action by the Securities and Exchange Commission. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

About Hagens Berman

Hagens Berman Sobol Shapiro LLP is an investor-rights class-action law firm with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the law firm and its successes can be found at www.hbsslaw.com. The Firm's securities law blog is at http://www.meaningfuldisclosure.com.

Firmani + Associates
Mark Firmani, 206-443 9357
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INTUITIVE SURGICAL
04/24Robotic Surgical Systems Market Analysis Trend, Growth, Volume, Size and Dema..
AQ
04/24INTUITIVE SURGICAL, INC. (NASDAQ : ISRG) Files An 8-K Submission of Matters to a..
AQ
04/23INTUITIVE SURGICAL INC : Submission of Matters to a Vote of Security Holders (fo..
AQ
04/19GLOBAL SURGICAL ROBOTS MARKET 2018- : 9strategy.biz added a depth and professio..
AQ
04/18INTUITIVE SURGICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
04/18INTUITIVE SURGICAL : Today’s Research Reports on Stocks to Watch: Intuitive Surg..
AC
04/18INTUITIVE SURGICAL, INC. (NASDAQ : ISRG) Files An 8-K Results of Operations and ..
AQ
04/17INTUITIVE SURGICAL INC : Results of Operations and Financial Condition (form 8-K..
AQ
04/17Intuitive Surgical Announces First Quarter Earnings
GL
04/17INTUITIVE SURGICAL : Intuitive Surgical, Inc. to Host Earnings Call
AC
More news
News from SeekingAlpha
04/26Earnings Season's Biggest Winners And Losers... So Far 
04/25Data problem leads NYSE to suspend trading for day in AMZN, GOOG, others 
04/24DAILY INSIDER RATINGS ROUND UP 4/20/ : Pdvw, smpl, ccur, dex, cik, eyeg 
04/19Technology Is Pushing Up Stocks - Cramer's Mad Money (4/18/18) 
04/18PREMARKET GAINERS AS OF 9 : 05 am (04/18/2018) 
Financials ($)
Sales 2018 3 614 M
EBIT 2018 1 431 M
Net income 2018 1 048 M
Finance 2018 3 097 M
Yield 2018 -
P/E ratio 2018 49,17
P/E ratio 2019 46,41
EV / Sales 2018 12,8x
EV / Sales 2019 11,2x
Capitalization 49 348 M
Chart INTUITIVE SURGICAL
Duration : Period :
Intuitive Surgical Technical Analysis Chart | ISRG | US46120E6023 | 4-Traders
Technical analysis trends INTUITIVE SURGICAL
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 477 $
Spread / Average Target 8,9%
EPS Revisions
Managers
NameTitle
Gary S. Guthart President, Chief Executive Officer & Director
Lonnie M. Smith Chairman
Salvatore J. Brogna Chief Operating Officer & Executive Vice President
Marshall L. Mohr Chief Financial Officer & Senior Vice President
Myriam J. Curet Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
INTUITIVE SURGICAL20.01%49 348
THERMO FISHER SCIENTIFIC12.95%85 763
DANAHER CORPORATION7.84%69 914
ROYAL PHILIPS9.96%39 965
BOSTON SCIENTIFIC CORPORATION14.97%39 316
ILLUMINA9.16%34 999